Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Immune Disease”

2,484 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,484 results

Testing effectiveness (Phase 2)Study completedNCT04882878
What this trial is testing

Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Janssen Research & Development, LLC 228
Not applicableNot Yet RecruitingNCT07130448
What this trial is testing

The Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)SLE - Systemic Lupus ErythematosusBiomarkers
Assiut University 120
Early research (Phase 1)UnknownNCT05474885
What this trial is testing

BCMA-CD19 cCAR T Cell Treatment of Relapsed/Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Relapsed/Refractory, Systemic Lupus Erythematosus (SLE)
iCell Gene Therapeutics 15
Testing effectiveness (Phase 2)Study completedNCT00807625
What this trial is testing

Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia

Who this might be right for
HIVContraceptionHIV Infections
University of Alabama at Birmingham 66
Not applicableStudy completedNCT04870359
What this trial is testing

Pre-emptive Treatments in Lupus Nephritis Patients With Serological Reactivation

Who this might be right for
Lupus Nephritis
The University of Hong Kong 49
Not applicableStudy completedNCT00029926
What this trial is testing

Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity

Who this might be right for
Lupus ErythematosusSystemic
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 20
Testing effectiveness (Phase 2)Study completedNCT03381625
What this trial is testing

Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis

Who this might be right for
PsoriasisAtopic Dermatitis
BioMimetix JV, LLC 139
Not applicableUnknownNCT05414162
What this trial is testing

Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy

Who this might be right for
DLBCLMultiple MyelomaCytokine Release Syndrome+6 more
University Hospital, Bonn 60
Not applicableUnknownNCT05863689
What this trial is testing

Microvascular Ocular Changes of Systemic Lupus Erythematous

Who this might be right for
Eye ManifestationsLupus Erythematosus, Systemic
Universidade do Porto 50
Early research (Phase 1)Looking for participantsNCT07031713
What this trial is testing

Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Testing effectiveness (Phase 2)UnknownNCT04924296
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 60
Not applicableUnknownNCT00519454
What this trial is testing

Estrogen and Gender Biased Autoimmunity

Who this might be right for
Systemic Lupus Erythematosus
The Center for Rheumatic Disease, Allergy, & Immunology 75
Large-scale testing (Phase 3)Enrolling By InvitationNCT04976322
What this trial is testing

Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
UCB Biopharma SRL 760
Testing effectiveness (Phase 2)Study completedNCT00506896
What this trial is testing

Monoarticular Corticosteroid Injection Versus Systemic Administration in the Treatment of Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Federal University of São Paulo 60
Not applicableLooking for participantsNCT04334031
What this trial is testing

Deployment o the Multidisciplinary Prospective Cohort Imminent

Who this might be right for
Chronic Inflammatory DiseaseAngioedemaSevere Asthma+6 more
University Hospital, Lille 2,200
Large-scale testing (Phase 3)Study completedNCT00646854
What this trial is testing

Alemtuzumab and CHOP in T-cell Lymphoma

Who this might be right for
Lymphoma, T-Cell, Peripheral
Aarhus University Hospital 136
Post-approval studies (Phase 4)WithdrawnNCT01926054
What this trial is testing

ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis

Who this might be right for
SLE Glomerulonephritis Syndrome, WHO Class V
Ohio State University
Not applicableStudy completedNCT00001131
What this trial is testing

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Not applicableStudy completedNCT02441166
What this trial is testing

Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis

Who this might be right for
Systemic Mastocytosis
University Hospital, Toulouse 250
Large-scale testing (Phase 3)Study completedNCT00991146
What this trial is testing

Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase

Who this might be right for
Cryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more
Novartis Pharmaceuticals 19
Load More Results